Javascript must be enabled to continue!
Comparison of Hypertonic Saline with Normal Saline Nebulization in the Management of Bronchiolitis in Children
View through CrossRef
Objective: “To compare the outcome of hypertonic saline with normal saline nebulization in management of bronchiolitis in children” Study design: Randomized controlled trial. Study place and duration: Department of Pediatrics, Hameed Latif Hospital, Lahore from 1st Oct 2024 to 15th April-2025. Methodology: Sixty infants fulfilling selection criteria were enrolled through emergency and were randomly divided in two groups. In group A, infants were given hypertonic (3%) saline nebulization. In group B, infants were given normal saline nebulization. Clinical severity score (CSS) was noted after 30, 60 and 120 minutes of nebulization and change in CSS was calculated. All the data was noted in proforma and analsyed in SPSS v.26. Results: At baseline, the median CSS score was 3.00 (IQR: 0.00) in bob groups, as all the infants has CSS score >2 at the time of presentation / enrolment. The median change after 30 minutes was observed as 1.00 (IQR: 1.00) with hypertonic saline and 1.00 (IQR: 0.25) with normal saline (p<0.05). The median change after 60 minutes was observed as 2.00 (IQR: 1.00) with hypertonic saline and 2.00 (IQR: 1.00) with normal saline (p<0.05). The median change after 120 minutes was observed as 3.00 (IQR: 1.00) with hypertonic saline and 2.00 (IQR: 0.25) with normal saline (p<0.05). Conclusion: The outcomes in terms of reduction in clinical severity score of bronchiolitis with hypertonic saline nebulization is better than normal saline nebulization.
Title: Comparison of Hypertonic Saline with Normal Saline Nebulization in the Management of Bronchiolitis in Children
Description:
Objective: “To compare the outcome of hypertonic saline with normal saline nebulization in management of bronchiolitis in children” Study design: Randomized controlled trial.
Study place and duration: Department of Pediatrics, Hameed Latif Hospital, Lahore from 1st Oct 2024 to 15th April-2025.
Methodology: Sixty infants fulfilling selection criteria were enrolled through emergency and were randomly divided in two groups.
In group A, infants were given hypertonic (3%) saline nebulization.
In group B, infants were given normal saline nebulization.
Clinical severity score (CSS) was noted after 30, 60 and 120 minutes of nebulization and change in CSS was calculated.
All the data was noted in proforma and analsyed in SPSS v.
26.
Results: At baseline, the median CSS score was 3.
00 (IQR: 0.
00) in bob groups, as all the infants has CSS score >2 at the time of presentation / enrolment.
The median change after 30 minutes was observed as 1.
00 (IQR: 1.
00) with hypertonic saline and 1.
00 (IQR: 0.
25) with normal saline (p<0.
05).
The median change after 60 minutes was observed as 2.
00 (IQR: 1.
00) with hypertonic saline and 2.
00 (IQR: 1.
00) with normal saline (p<0.
05).
The median change after 120 minutes was observed as 3.
00 (IQR: 1.
00) with hypertonic saline and 2.
00 (IQR: 0.
25) with normal saline (p<0.
05).
Conclusion: The outcomes in terms of reduction in clinical severity score of bronchiolitis with hypertonic saline nebulization is better than normal saline nebulization.
Related Results
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
AimsRecent conclusive evidence has suggested that, contrary to previous limited evidence, there is no benefit to the use of 3% hypertonic saline (3% HS) in the treatment of bronchi...
Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
Introduction:
Several drugs are in use for nebulization in children with acute bronchiolitis and no study has yet been conducted to compare the treatment outcome of neb...
Terapi Nebulasi pada Pasien Anak dengan Bronkiolitis
Terapi Nebulasi pada Pasien Anak dengan Bronkiolitis
This study aims to determine which nebulization therapy is effective for improving respiratory status and reducing the length of stay in children with bronchiolitis. The research m...
Serum Vitamin D Level in Children With Bronchiolitis
Serum Vitamin D Level in Children With Bronchiolitis
Abstract
Acute bronchiolitis is the most common lower respiratory tract infection during the first year of life. Vitamin D is an important contributing factor to th...
Comparison of hypertonic-saline vs normal-saline nebulization in children with bronchiolitis.
Comparison of hypertonic-saline vs normal-saline nebulization in children with bronchiolitis.
Objective: To compare the efficacy of 3% hypertonic saline (HS) with normal saline (NS) in children with bronchiolitis, in term of change in clinical severity score and duration of...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
LONG-TERM USE OF INHALED HYPERTONIC SALINE IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS: EXPERIENCE FROM A TERTIARY CARE CENTER IN A LOW AND MIDDLE INCOME COUNTRY
LONG-TERM USE OF INHALED HYPERTONIC SALINE IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS: EXPERIENCE FROM A TERTIARY CARE CENTER IN A LOW AND MIDDLE INCOME COUNTRY
Background Long term hypertonic saline use has been found to improve mucus transport, airway hydration, and mucociliary clearance in patients with cystic fibrosis. However, the eff...
Early Halt of a Randomized Controlled Study with 3% Hypertonic Saline in Acute Bronchiolitis
Early Halt of a Randomized Controlled Study with 3% Hypertonic Saline in Acute Bronchiolitis
<b><i>Background:</i></b> Albeit not recommended because of contradictory results, nebulized 3% hypertonic saline is widely used for treating acute viral br...

